Side effects associated with influenza vaccination in healthy working adults. A randomized, placebo-controlled trial
- PMID: 8687262
Side effects associated with influenza vaccination in healthy working adults. A randomized, placebo-controlled trial
Abstract
Background: Concern about side effects is a barrier to influenza vaccination. This randomized, double-blind, placebo-controlled trial assessed side effects following vaccination among healthy working adults.
Methods: Healthy working adults were recruited during October and November 1994 and were randomized to receive influenza vaccine or placebo injections. Local and systemic symptoms during the week following the injection were evaluated through structured telephone interviews.
Results: Of 849 subjects enrolled in the study, 425 received a placebo and 424 received influenza vaccine. Baseline characteristics were similar between the groups, and 99% of subjects completed interviews to assess side effects after the study injection. No differences were seen between the 2 groups for the systemic symptoms of fever, myalgias, fatigue, malaise, or headaches. Overall, 35.2% of placebo and 34.1% of vaccine recipients reported at least 1 of these systemic symptoms (P = .78, chi 2). Vaccine recipients reported a higher rate of arm soreness at the injection site than did placebo recipients (63.8% vs 24.1%, P < .001). Local reactions were mild in both groups and infrequently resulted in decreased use of the arm. After logistic regression, female sex (odds ratio [OR], 1.5;95% confidence interval [CI], 1.1-2.1), age younger than 40 years (OR, 1.6;95% CI, 1.2-2.2), and coincidental upper respiratory tract illness (OR, 4.6; 95% CI, 3.2-6.6) were independently associated with higher rates of systemic symptoms. In the multivariate model, vaccine again was not associated with systemic symptoms (OR, 0.9; 95% CI, 0.7-1.2).
Conclusions: Influenza vaccination of healthy working adults is not associated with higher rates of systemic symptoms when compared with placebo injection. These findings should be useful to physicians and other health care providers as they counsel patients to take advantage of an important opportunity for disease prevention and health protection.
Similar articles
-
Adverse effects associated with influenza vaccination in patients with COPD: a randomized controlled study.Respirology. 2004 Nov;9(4):550-6. doi: 10.1111/j.1440-1843.2004.00616.x. Respirology. 2004. PMID: 15612969 Clinical Trial.
-
Half- vs full-dose trivalent inactivated influenza vaccine (2004-2005): age, dose, and sex effects on immune responses.Arch Intern Med. 2008 Dec 8;168(22):2405-14. doi: 10.1001/archinternmed.2008.513. Arch Intern Med. 2008. PMID: 19064822 Clinical Trial.
-
The effectiveness of vaccination against influenza in healthy, working adults.N Engl J Med. 1995 Oct 5;333(14):889-93. doi: 10.1056/NEJM199510053331401. N Engl J Med. 1995. PMID: 7666874 Clinical Trial.
-
Systemic vasculitis following influenza vaccination--report of 3 cases and literature review.J Rheumatol. 1993 Aug;20(8):1429-31. J Rheumatol. 1993. PMID: 8230034 Review.
-
Influenza vaccination: is it appropriate in chronic fatigue syndrome?Am J Respir Med. 2002;1(1):3-9. doi: 10.1007/BF03257157. Am J Respir Med. 2002. PMID: 14720070 Review.
Cited by
-
Using smartphones to study vaccination decisions in the wild.PLOS Digit Health. 2024 Aug 8;3(8):e0000550. doi: 10.1371/journal.pdig.0000550. eCollection 2024 Aug. PLOS Digit Health. 2024. PMID: 39116047 Free PMC article.
-
Patient-reported reactogenicity and safety of COVID-19 vaccinations vs. comparator vaccinations: a comparative observational cohort study.BMC Med. 2023 Sep 19;21(1):358. doi: 10.1186/s12916-023-03064-6. BMC Med. 2023. PMID: 37726711 Free PMC article.
-
Short-term Side Effects of mRNA-based COVID-19 Vaccine Among Jordanian Population; a Cross-sectional Study.Arch Acad Emerg Med. 2023 Feb 12;11(1):e22. doi: 10.22037/aaem.v11i1.1850. eCollection 2023. Arch Acad Emerg Med. 2023. PMID: 36919138 Free PMC article.
-
COVID-19 and Bangladeshi health professionals: Infection status, vaccination and its immediate health consequences.PLoS One. 2022 Nov 15;17(11):e0277022. doi: 10.1371/journal.pone.0277022. eCollection 2022. PLoS One. 2022. PMID: 36378639 Free PMC article.
-
Association of post-vaccination adverse reactions after influenza vaccine with mortality and cardiopulmonary outcomes in patients with high-risk cardiovascular disease: the INVESTED trial.Eur J Heart Fail. 2023 Feb;25(2):299-310. doi: 10.1002/ejhf.2716. Epub 2022 Nov 6. Eur J Heart Fail. 2023. PMID: 36335639 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical